University of California, Santa Cruz Researchers Strive to Enhance Milk Production With $150,000 Zoetis Grant
Drs. Hinck and Chatterjee awarded Zoetis Cattle Call research funding
FLORHAM PARK, N.J., July 28, 2015 — Researchers at the University of California, Santa Cruz will continue research related to mammary gland development, thanks to $150,000 in research funding from Zoetis. The award is part of the competitive Zoetis Cattle Call research grant program, which supports efforts by North American researchers and veterinarians to improve dairy and beef cattle performance.
This year’s grant recipients, Lindsay Hinck, Ph.D., professor of Molecular, Cell and Developmental Biology, along with Sharmila Chatterjee, Ph.D., a postdoctoral scholar, are working on basic research that could identify potential pathways to higher milk production in dairy cattle.
Dr. Hinck’s research lab studies mammary gland development and stem cell biology, focusing primarily on human breast cancer.
“I had never thought about the practical role our research could play in the dairy industry,” Dr. Hinck said. “It turns out that our investigation into regulatory mechanisms governing mammary stem cells can directly translate to milk production. This is a new and exciting direction for our research program.”
“Basic biological research is the foundation for solutions that could help improve cattle health and productivity in the future,” explained Roger Saltman, DVM, MBA, group director of Cattle and Equine Technical Services at Zoetis. Dr. Saltman is part of the Zoetis research committee that evaluates Cattle Call grant applications.
“We see many innovative ideas through our Cattle Call research grant program,” Dr. Saltman said. “What’s interesting about this proposal is that mammary development is a fundamental process that is not fully understood. Research such as this holds great promise for the dairy industry as we strive to get more milk from the same number of cows.”
Zoetis (zō-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. In 2014, the company generated annual revenue of $4.8 billion. With approximately 10,000 employees worldwide at the beginning of 2015, Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in 120 countries. For more information, visit www.zoetisUS.com.
For Further Information, Contact:
- Belgium (French)
- Belgium (Dutch)
- Costa Rica
- Czech Republic
- New Zealand
- South Africa
- South Korea
- United Kingdom
- United States